Attività della Fondazione

Patterns of Comorbidities in Lung Cancer Patients and Survival
NSCLC

Evaluation of the impact of the introduction of the clinical pathway on health outcome and costs and quality of care in Non-small cell lung cancer (NSCLC) patients
Studio “O.Co.Ca” (in corso)

VEneto and ROmagna Breast project
Studio “VERO” (in corso)

Confronto analitico per la valutazione e monitoraggio degli indicatori per la terapia adiuvante e neoadiuvante del tumore mammario ricavati da dati amministrativi elettronici da archivio sanitario centro-specifico
Studio “PERSEO” – PERiplo SEnO (in fase di attivazione)

Progetto (in corso) di finanziamento per l’acquisto di parrucche come presidio sanitario di supporto psicologico e sociale in pazienti con carcinoma mammario trattate con chemioterapia alopecizzante

Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease model
Estimated costs NSCLC

Non–Small-Cell Lung Cancer: Real-World Cost Consequence Analysis
NSCLC costs ROV JOP 2021

Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy
Periplo BREAST JOP

Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards
Periplo ESMO Open

NON-SMALL-CELL LUNG CANCER: Real-World Population-Based Cohorts’ Study
RW Lung Cancers

Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review
TNBC Consensus 2023